UT graduate student Angela Wagner is co-developing a new drug called Zepatier which treats hepatitis C. Zepatier would be an important medical advance because it is more affordable than current medication and it is only one pill a day as opposed to eighteen.

Photo Credit: Fabiana Peña Feeney